Skip to main content

Client News

Mainz Biomed Secures up to $50m in New Funding

29th June 2023

Carbios incorporates its Purpose into company statutes and presents the results of its Special Meeting and Annual General Meeting of 22 June 2023

28th June 2023

InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer

28th June 2023

Affluent Medical Presents Poster on First Successful Procedure with Epygon at the 2023 CSI Conference in Frankfurt

28th June 2023

Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain

28th June 2023

Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis

22nd June 2023

MIG Capital: MIG Capital co-leads seed investment in French space tech company Look Up Space

22nd June 2023

Carbios announces the launch of a rights issue totalling around €122 million, likely to be increased to around €141 million if the extension clause is fully exercised

22nd June 2023

InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients

21st June 2023

Mainz Biomed Expands into Romania through Partnership with Bioclinica

20th June 2023